We are live on ! Find out more
AXDX

Accelerate Diagnostics
AXDX

Delisted

AXDX was delisted on the 14th of May, 2025.

Back to rankings

99 hedge funds and large institutions have $205M invested in Accelerate Diagnostics in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 36 increasing their positions, 36 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 36

3% less capital invested

Capital invested by funds: $211M → $205M (-$6.07M)

14% less funds holding

Funds holding: 115 → 99 (-16)

50% less call options, than puts

Call options by funds: $1.1M | Put options by funds: $2.22M

76% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 17

Holders
99
Holders Change
-16
Holders Change %
-13.91%
% of All Funds
1.74%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
4
Increased
36
Reduced
36
Closed
17
Calls
$1.1M
Puts
$2.22M
Net Calls
-$1.11M
Net Calls Change
+$849K

Top Buyers

Rank Fund Capital Flow
1
William Blair & Company
William Blair & Company
Illinois
+$5.98M
2
Rafferty Asset Management
Rafferty Asset Management
New York
+$2.86M
3
GCM
Graham Capital Management
Connecticut
+$852K
4
BlackRock
BlackRock
New York
+$672K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$622K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$10.9M
2
CS
Credit Suisse
Switzerland
-$9.87M
3
CWG
C WorldWide Group
Denmark
-$3.98M
4
Two Sigma Investments
Two Sigma Investments
New York
-$1.64M
5
OCMI
Oaktop Capital Management II
New Jersey
-$1.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$1.06M +$125K +1,235 +11%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$997K -$203 -2 -0%
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$931K -$274K -2,700 -19%
GCM
29
Graham Capital Management
Connecticut
$698K +$852K +8,400 New
Renaissance Technologies
30
Renaissance Technologies
New York
$662K -$1.07M -10,588 -57%
Millennium Management
31
Millennium Management
New York
$607K +$460K +4,530 +164%
Swiss National Bank
32
Swiss National Bank
Switzerland
$597K +$31.4K +310 +5%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$527K – – –
TIM
34
Thompson Investment Management
Wisconsin
$507K – – –
Morgan Stanley
35
Morgan Stanley
New York
$503K -$1M -9,864 -62%
Two Sigma Investments
36
Two Sigma Investments
New York
$462K -$1.64M -16,153 -74%
TWA
37
TCI Wealth Advisors
Arizona
$462K – – –
Asset Management One
38
Asset Management One
Japan
$450K +$150K +1,474 +37%
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$410K +$25.8K +254 +5%
Principal Financial Group
40
Principal Financial Group
Iowa
$367K +$33.5K +330 +8%
Mitsubishi UFJ Asset Management
41
Mitsubishi UFJ Asset Management
Japan
$361K +$155K +1,524 +54%
AF
42
Allworth Financial
California
$333K +$91.3K +900 +29%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$309K -$18K -177 -5%
Tudor Investment Corp
44
Tudor Investment Corp
Connecticut
$300K -$820K -8,080 -69%
CL
45
CSS LLC
Illinois
$300K – – –
Citadel Advisors
46
Citadel Advisors
Florida
$298K +$222K +2,187 +157%
AllianceBernstein
47
AllianceBernstein
Tennessee
$287K -$132K -1,300 -27%
Goldman Sachs
48
Goldman Sachs
New York
$270K +$14K +138 +4%
UBS AM
49
UBS AM
Illinois
$258K – – –
CIBC Private Wealth Group
50
CIBC Private Wealth Group
Georgia
$255K -$27K -266 -8%
1
2
3 4 5

AXDX Hedge Fund Activity: Q1 2021 in Review

99 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q1 2021, worth a combined $205M — down 2.9% from $211M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of AXDX and 4 opened new positions — a net loss of 13 holders — while 36 trimmed existing stakes and 36 added.

The largest buyer was William Blair & Company, adding an estimated $5.98M. The largest seller was Fidelity Investments, exiting entirely with an estimated $10.9M sold.

  • 99 institutional investors held Accelerate Diagnostics (AXDX) as of Q1 2021, down from 115 in Q4 2020.
  • Funds reported $205M of Accelerate Diagnostics stock for Q1 2021, down 2.9% quarter-over-quarter.
  • 4 funds opened new Accelerate Diagnostics positions in Q1 2021 and 17 closed out, a net change of -13 holders.
  • The largest Accelerate Diagnostics buyer in Q1 2021 was William Blair & Company, an estimated $5.98M added.
  • The largest Accelerate Diagnostics seller in Q1 2021 was Fidelity Investments, an estimated $10.9M sold.

Based on aggregated 13F filings for Q1 2021.